Methylphenidate increases creatine kinase activity in the brain of young and adult rats

Life Sciences

Volumn 83, Issue 23-24, 2008, Pages 795-800

  Scaini, Giselli ^a   Fagundes, Ana O ^a   Rezin, Gislaine T ^a   Gomes, Karin M ^a   Zugno, Alexandra I ^a   Quevedo, João ^a   Streck, Emilio L ^a  

^a UNIVERSIDADE DO EXTREMO SUL CATARINENSE   (Brazil)

Author keywords

Brain; Creatine kinase; Metabolism; Methylphenidate

Indexed keywords

CREATINE KINASE; METHYLPHENIDATE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN HOMOGENATE; CONTROLLED STUDY; CORPUS STRIATUM; ENZYME ACTIVITY; HIPPOCAMPUS; MALE; NONHUMAN; PERINATAL PERIOD; PREFRONTAL CORTEX; RAT;

AGING; ANIMALS; BRAIN; CENTRAL NERVOUS SYSTEM STIMULANTS; CREATINE KINASE; DRUG ADMINISTRATION SCHEDULE; MALE; METHYLPHENIDATE; RATS; RATS, WISTAR;

RATTUS;

EID: 55749098781     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2008.09.019     Document Type: Article

References (51)

1. Aksenov M., Aksenov M., Butterfield D.A., and Markesbery W.R. Oxidative modification of creatine kinase BB in Alzheimer's disease brain. Journal of Neurochemistry 74 (2000) 2520-2527
2. Assis L.C., Scaini G., Di-Pietro P.B., Castro A.A., Comim C.M., Streck E.L., and Quevedo J. Effect of antipsychotics on creatine kinase activity in rat brain. Basic & Clinical Pharmacology & Toxicology 101 (2007) 315-319
3. Bessman S.P., and Carpenter C.L. The creatine-creatine phosphate energy shuttle. Annual Review of Biochemistry 54 (1985) 831-865
4. Biederman J., and Faraone S.V. Attention-deficit hyperactivity disorder. Lancet 366 (2005) 237-248
5. Biederman J., Mick E., and Faraone S.V. Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type. The American Journal of Psychiatry 157 (2000) 816-818
6. Blass J.P. Brain metabolism and brain disease: is metabolic deficiency the proximate cause of Alzheimer dementia?. Journal of Neuroscience Research 66 (2001) 851-856
7. Botly L.C., Burton C.L., Rizos Z., and Fletcher P.J. Characterization of methylphenidate self-administration and reinstatement in the rat. Psychopharmacology 199 (2008) 55-66
8. Brandon C.L., and Steiner H. Repeated methylphenidate treatment in adolescent rats alters gene regulation in the striatum. The European Journal of Neuroscience 18 (2003) 1584-1592
9. Burigo M., Roza C.A., Bassani C., Feier G., Dal-Pizzol F., Quevedo J., and Streck E.L. Decreased creatine kinase activity caused by electroconvulsive shock. Neurochemical Research 31 (2006) 877-881
10. Challman T.D., and Lipsky J.J. Methylphenidate: its pharmacology and uses. Mayo Clinic Proceedings 75 (2000) 711-721
11. Chase T.D., Brown R.E., Carrey N., and Wilkinson M. Daily methylphenidate administration attenuates c-fos expression in the striatum of prepubertal rats. Neuroreport 14 (2003) 769-772
12. Chase T.D., Carrey N., Soo E., and Wilkinson M. Methylphenidate regulates activity regulated cytoskeletal associated but not brain-derived neurotrophic factor gene expression in the developing rat striatum. Neuroscience 144 (2007) 969-984
13. David S., Shoemaker M., and Haley B.E. Abnormal properties of creatine kinase in Alzheimer's disease brain: correlation of reduced enzyme activity and active site photolabeling with aberrant cytosol-membrane partitioning. Molecular Brain Research 54 (1998) 276-287
14. Fagundes A.O., Rezin G.T., Zanette F., Grandi E., Assis L.C., Dal-Pizzol F., Quevedo J., and Streck E.L. Chronic administration of methylphenidate activates mitochondrial respiratory chain in brain of young rats. International Journal of Developmental Neuroscience 25 (2007) 47-51
15. Federici M., Geracitano R., Bernardi G., and Mercuri N.B. Actions of methylphenidate on dopaminergic neurons of the ventral midbrain. Biological Psychiatry 57 (2005) 361-365
16. Fukui R., Svenningsson P., Matsuishi T., Higashi H., Nairn A.C., Greengard P., and Nishi A. Effect of methylphenidate on dopamine/DARPP signalling in adult, but not young, mice. Journal of Neurochemistry 87 (2003) 1391-1401
17. Garland E.J. Pharmacotherapy of adolescent attention deficit hyperactivity disorder: challenges, choices, caveats. Journal of Psychopharmacology 12 (1998) 385-395
18. Gerasimov M.R., Franceschi M., Volkow N.D., Rice O., Schiffer W.K., and Dewey S.L. Synergistic interactions between nicotine and cocaine or methylphenidate depend on the dose of dopamine transporter inhibitor. Synapse 38 (2000) 432-437
19. Gray J.D., Punsoni M., Tabori N.E., Melton J.T., Fanslow V., Ward M.J., Zupan B., Menzer D., Rice J., Drake C.T., Romeo R.D., Brake W.G., Torres-Reveron A., and Milner T.A. Methylphenidate administration to juvenile rats alters brain areas involved in cognition, motivated behaviors, appetite, and stress. The Journal of Neuroscience 27 (2007) 7196-7207
20. Greenhill L.L. Clinical effects of stimulant medication in attention-deficit/hyperactivity disorder (ADHD). In: Solanto, M.V., Arnsten, A.F.T., Castellanos, and F.X. (Eds). Stimulant Drugs and ADHD: Basic and Clinical Neuroscience (2001), Oxford Univ. Press, New York 31-71
21. Greenhill L.L., Pliszka S., Dulcan M.K., Bernet W., Arnold V., Beitchman J., Benson R.S., Bukstein O., Kinlan J., McClellan J., Rue D., Shaw J.A., Stock S., and Kroeger K. Summary of the practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. Journal of the American Academy of Child and Adolescent Psychiatry 40 (2001) 1352-1355
22. Gross W.L., Bak M.I., Ingwall J.S., Arstall M.A., Smith T.W., Balligand J.L., and Kelly R.A. Nitric oxide inhibits creatine kinase and regulates rat heart contractile reserve. Proceedings of the National Academy of Sciences of United States of America 93 (1996) 5604-5609
23. Grund T., Lehmann K., Bock N., Rothenberger A., and Teuchert-Noodt G. Influence of methylphenidate on brain development-an update of recent animal experiments. Behavioral and Brain Functions 2 (2006) 2
24. Heales S.J., Bolaños J.P., Stewart V.C., Brookes P.S., Land J.M., and Clark J.B. Nitric oxide, mitochondria and neurological disease. Biochimica et Biophysica Acta 1410 (1999) 215-228
25. Hughes B.P. A method for estimation of serum creatine kinase and its use in comparing creatine kinase and aldolase activity in normal and pathologic sera. Clinica Chimica Acta 7 (1962) 597-604
26. Khuchua Z.A., Qin W., Boero J., Cheng J., Payne R.M., Saks V.A., and Strauss A.W. Octamer formation and coupling of cardiac sarcomeric mitochondrial creatine kinase are mediated by charged N-terminal residues. The Journal of Biological Chemistry 273 (1998) 22990-22996
27. Klein-Schwartz W. Pediatric methylphenidate exposures: 7-year experience of poison centers in the United States. Clinical Pediatrics 42 (2003) 159-164
28. Kolb B., Gorny G., Li Y., Samaha A.N., and Robinson T.E. Amphetamine or cocaine limits the ability of later experience to promote structural plasticity in the neocortex and nucleus accumbens. Proceedings of the National Academy of Science of the United States of America 100 (2003) 10523-10528
29. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. The Journal of Biological Chemistry 193 (1951) 265-267
30. Mague S.D., Andersen S.L., and Carlezon W.A. Early developmental exposure to methylphenidate reduces cocaine-induced potentiation of brain stimulation reward in rats. Biological Psychiatry 57 (2005) 120-125
31. Mannuzza S., Klein R.G., Bessler A., Malloy P., and Hynes M.E. Educational and occupational outcome of hyperactive boys grown up. Journal of the American Academy of Child and Adolescent Psychiatry 36 (1997) 1222-1227
32. Mannuzza S., Klein R.G., Bessle A., Malloy P., and LaPadula M. Adult psychiatric status of hyperactive boys grown up. The American Journal of Psychiatry 155 (1998) 493-498
33. Penner M.R., McFadyen M.P., Pinaud R., Carrey N., Robertson H.A., and Brown R.E. Age-related distribution of c-fos expression in the striatum of CD-1 mice after acute methylphenidate administration. Brain Research. Developmental Brain Research 135 (2002) 71-77
34. Porrino L.J., and Lucignani G. Different patterns of local brain energy metabolism associated with high and low doses of methylphenidate. Relevance to its action in hyperactive children. Biological Psychiatry 22 (1987) 126-138
35. Ricaurte G.A., Mechan A.O., Yuan J., Hatzidimitriou G., Xie T., Mayne A.H., and McCann U.D. Amphetamine treatment similar to that used in the treatment of adult attention-deficit/hyperactivity disorder damages dopaminergic nerve endings in the striatum of adult nonhuman primates. The Journal of Pharmacology and Experimental Therapeutics 315 (2005) 91-98
36. Safer D.J., and Allen R.P. Absence of tolerance to the behavioral effects of methylphenidate in hyperactive and inattentive children. The Journal of Pediatrics 115 (1989) 1003-1008
37. Schlattner U., and Wallimann T. Octamers of mitochondrial creatine kinase isoenzymes differ in stability and membrane binding. The Journal of Biological Chemistry 275 (2000) 17314-17320
38. Schurr A. Energy metabolism, stress hormones and neural recovery from cerebral ischemia/hypoxia. Neurochemistry International 41 (2002) 1-8
39. Streck E.L., Amboni G., Scaini G., Di-Pietro P.B., Rezin G.T., Valvassori S.S., Luz G., Kapczinski F., and Quevedo J. Brain creatine kinase activity in an animal model of mania. Life Sciences 82 (2008) 424-429
40. Teo S.K., San R.H., Wagner V.O., Gudi R., Stirling D.I., Thomas S.D., and Khetani V.D. D-Methylphenidate is non-genotoxic in in vitro and in vivo assays. Mutation Research 537 (2003) 67-79
41. Tomimoto H., Yamamoto K., Homburger H.A., and Yanagihara T. Immunoelectron microscopic investigation of creatine kinase BB-isoenzyme after cerebral ischemia in gerbils. Acta Neuropathologica 86 (1993) 447-455
42. Valvassori S.S., Frey B.N., Martins M.R., Reus G.Z., Schimidtz F., Inácio C.G., Kapczinski F., and Quevedo J. Sensitization and cross-sensitization after chronic treatment with methylphenidate in adolescent Wistar rats. Behavioural Pharmacology 18 (2007) 205-212
43. Volkow N.D. Stimulant medications: how to minimize their reinforcing effects?. The American Journal of Psychiatry 163 (2006) 359-361
44. Volkow N.D., Wang G.J., Fowler J.S., Gatley S.J., Logan J., and Ding Y.S. Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. The American Journal of Psychiatry 155 (1998) 1325-1331
45. Volkow N.D., Wang G., Fowler J.S., and Ding Y. Imaging the effects of methylphenidate on brain dopamine: new model on its therapeutic actions for attention-deficit/hyperactivity disorder. Biological Psychiatry 57 (2005) 1410-1415
46. Wallimann T., Wyss M., Brdiczka D., Nicolay K., and Eppenberger H.M. Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the 'phosphocreatine circuit' for cellular energy homeostasis. The Biochemical Journal 281 (1992) 21-40
47. Wigal T., Swanson J.M., Regino R., Lerner M.A., Soliman I., and Steinhoff K. Stimulant medications for the treatment of ADHD: efficacy and limitations. Mental Retardation and Developmental Disabilities Research Reviews 5 (1999) 215-224
48. Wilens T.E. Effects of methylphenidate on the catecholaminergic system in attention-deficit/hyperactivity disorder. Journal of Clinical Psychopharmacology 28 (2008) S46-53
49. Yano M., and Steiner H. Methylphenidate (Ritalin) induces Homer 1a and zif 268 expression in specific corticostriatal circuits. Neuroscience 132 (2005) 855-865
50. Yano, M., Steiner, and H. Methylphenidate and cocaine: the same effects on gene regulation?. Trends in Pharmacological Sciences 28 (2007) 588-596
51. Zanette F., Victor E.G., Scaini G., Di-Pietro P.B., Cardoso D.C., Cristiano M.P., Dal-Pizzol F., Paula M.M., and Streck E.L. Modulation of creatine kinase activity by ruthenium complexes. Journal of Inorganic Biochemistry 101 (2007) 267-273